InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the detailed record of transactions filed by McCarthy Christopher. Director active across 1 company, notably Interpace Biosciences, INC.. In total, 4 reports have been published. Activity tracked since 31 July 2023. The latest transaction was filed on 20 August 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations